Net Income

Tabnine's new Enterprise Context Engine promises to solve AI's reliability gap by building a living model of an organization's systems and knowledge.

In its debut, Identy.io achieves top-tier NIST results, challenging industry giants with superior speed and accuracy for border and national security.

New research reveals a massive trust gap in healthcare AI as overall confidence drops. Why are users believers while the vast majority of Americans remain wary?

Sarepta will unveil crucial long-term data for its Duchenne gene therapy and exon-skipping drugs at MDA 2026, a pivotal moment for patients and the company.

The Swedish freight-tech firm secures new funding for its SPAC merger, fueling a global push for its electric and autonomous trucking ecosystem.

Broadcom ships a revolutionary 2nm chip with 3.5D 'face-to-face' stacking, promising unprecedented power and efficiency for the next generation of AI.

A new platform powered by Alpaca's API aims to solve fragmentation for Muslim investors, targeting a global Islamic finance market set to hit $9.7 trillion.

With a massive new investment led by NewSpring, physician-led Honest Health is set to expand its mission of transforming healthcare from volume to value.

The Daytime Dining leader heads to three major investor conferences with a record of rapid expansion, but faces questions on traffic, inflation, and its 2026 outlook.

NextPlat's Orbital Satcom enters five LATAM markets via e-commerce giant Mercado Libre, aiming to connect millions in a region hungry for satellite tech.

After a banner 2025, TriMas is selling its aerospace unit to double down on packaging, armed with a major cash infusion and a new efficiency plan.

With the hire of Greg Crescenzi, the famed academic repository signals a major strategic expansion to bridge the gap between scientific sharing and drug development.

Stratasys' EcoVadis Gold Medal places it in the top 5% globally, signaling a major shift toward sustainable practices in the additive manufacturing industry.

The strategic acquisition unites two leaders in pipe rehabilitation, signaling a major consolidation in the booming market for fixing aging water infrastructure.

Heron Therapeutics posts record growth fueled by ZYNRELEF and APONVIE, issuing strong 2026 guidance and signaling a successful pivot to profitability.

The Singaporean facilities firm lands major residential deals, bolstering its recurring revenue as it navigates financial headwinds with a push in AI robotics.

A consulting firm's work optimizing ORs and sterile processing impacted over 1 million patients, revealing the crucial link between logistics and patient care.

Nautilus Biotechnology cuts losses and preps its Voyager platform for a late 2026 launch, targeting the next frontier in neurodegenerative disease research.

Cannara Biotech's graduation to the TSX, backed by strong financials and new analyst coverage, marks a pivotal moment for the company and the cannabis sector.

The burger chain posted robust revenue and a massive jump in annual net income, outperforming rivals and detailing plans for major global expansion.